Metabolic reprogramming is the review's umbrella concept for shifts in cellular metabolism associated with activation, proliferation, differentiation, inflammation, and disease. The paper compares this process across immune cells and endothelial cells.
First-pass extracted concept
metabolic reprogramming
Extracted Explainers
What the tool is doing
What problem it solves
Evidence Snippets
metabolic reprogramming
We discuss strategies that incorporate cytokine engineering, metabolic reprogramming, and logic-gated activation to counteract the immunosuppressive tumor microenvironment.
Metabolic reprogramming in immune and endothelial cells (ECs) is being studied extensively... nitric oxide, hypoxia-inducible factor, and adenosine monophosphate-activated protein kinase have been discussed for their common involvement in metabolic reprogramming of both systems.
Supporting Sources
Linked Claims
Optimizing CARs for NK cells, integrating immune checkpoint resistance, metabolic reprogramming, and cytokine support are genetic engineering strategies intended to improve NK-cell survival and potency.
We discuss the optimization of chimeric antigen receptors (CARs) specifically for NK cells, the integration of immune checkpoint resistance, metabolic reprogramming, and the incorporation of cytokine support to improve survival and potency.
Cytokine engineering, metabolic reprogramming, and logic-gated activation are discussed as strategies to counteract the immunosuppressive tumor microenvironment.
Immune cells and endothelial cells can both undergo a Warburg-like metabolic switch that favors glycolysis over oxidative phosphorylation under aerobic conditions.
Metabolic reprogramming in immune cells and endothelial cells is relevant not only in health but also in pathological states including atherosclerosis and cancer.
In vitro and animal studies show discrepancies regarding the effects of nitric oxide, hypoxia-inducible factor, and AMP-activated protein kinase on the metabolic switch.
Nitric oxide, hypoxia-inducible factor, and AMP-activated protein kinase are discussed as common regulators involved in metabolic reprogramming in both immune and endothelial systems.